经腋窝第一肋切除术后静脉性胸廓出口综合征完全闭塞静脉的手术结局
本回顾性机构审查纳入2003至2022年因静脉性胸廓出口综合征伴腋锁骨下静脉完全闭塞而接受经腋窝第一肋切除术的103例患者,按闭塞至手术时间分为<4周、4至12周和>12周3组,比较1年通畅率与症状改善,结果显示各组结局无显著差异。
要点
- 术后2至3周静脉造影显示3组再通比例分别为78.6%、72.2%和61.5%,差异无统计学意义(P = .76)。
- 随访10至14个月,3组静脉通畅比例分别为79.2%、73.3%和73.3%,差异无统计学意义(P = .86)。
- 至14个月时,95.2%的患者症状改善,75%获得静脉通畅。
核心结论
- 经腋窝第一肋切除术对有症状的静脉性胸廓出口综合征患者可获得良好的术后结局,即使腋锁骨下静脉完全闭塞,无论闭塞时间长短。
- 至14个月时,95.2%的患者症状改善,75%获得静脉通畅。
研究设计与样本
- 回顾性机构审查,纳入2003年至2022年因静脉性胸廓出口综合征伴腋锁骨下静脉完全闭塞而接受经腋窝第一肋切除术的患者。
- 共103例患者,中位年龄30.0岁,女性占42.7%,非白人占8.8%。
- 按诱发静脉性胸廓出口综合征事件至经腋窝第一肋切除术的时间分为3组:<4周28例、4至12周36例、>12周39例。
- 采用χ2检验比较基线特征与术后结局。
主要发现
- 术后2至3周静脉造影显示,<4周组78.6%、4至12周组72.2%、>12周组61.5%存在一定程度再通(P = .76)。
- 随访10至14个月,超声检查显示<4周组79.2%、4至12周组73.3%、>12周组73.3%腋锁骨下静脉通畅(P = .86)。
- 术后接受球囊血管成形术的患者中,<4周组80.0%、4至12周组85.0%、>12周组100%在10至14个月时保持通畅(P = .31)。
- 症状改善比例分别为<4周组95.7%、4至12周组96.7%、>12周组93.5%(P = .84)。
- 术后静脉造影时对60例存在腋锁骨下静脉狭窄或闭塞的患者成功实施了球囊血管成形术。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Surgical decompression via transaxillary first rib resection (TFRR) is often performed in patients presenting with venous thoracic outlet syndrome (VTOS). We aimed to evaluate the outcomes of TFRR based on chronicity of completely occluded axillosubclavian veins in VTOS. METHODS: We performed a retrospective institutional review of all patients who underwent TFRR for VTOS and had a completely occluded axillosubclavian vein between 2003 and 2022. Patients were categorized into three groups based on the time of inciting VTOS event to TFRR acuity of their venous occlusion: <4 weeks, 4 to 12 weeks, and >12 weeks. We evaluated the association of TFRR timing with 1-year outcomes, including patency and symptomatic improvement. We used the χ2 test to compare baseline characteristics and postoperative outcomes. RESULTS: Overall, 103 patients underwent TFRR for VTOS with a completely occluded axillosubclavian vein (median age, 30.0 years; 42.7% female; 8.8% non-White), of whom 28 had occlusion at <4 weeks, 36 had occlusion at 4 to 12 weeks, and 39 had occlusion at >12 weeks. Postoperative venogram performed 2 to 3 weeks after TFRR demonstrated that 78.6% in the <4 weeks group, 72.2% in the 4- to 12-weeks group, and 61.5% in the >12 weeks group had some degree of recanalization (P = .76). Postoperative balloon angioplasty was successfully performed in 60 patients with stenosed or occluded axillosubclavian vein at the time of postoperative venogram. At the 10- to 14-month follow-up, 79.2% of the <4 weeks group, 73.3% of the 4- to 12-weeks group, and 73.3% of the >12 weeks group had patent axillosubclavian veins based on duplex ultrasound examination (P = .86). Among patients who underwent postoperative balloon angioplasty, 80.0%, 85.0% and 100% in the <4 weeks, 4- to 12-weeks, and >12 weeks groups respectively demonstrated patency at 10 to 14 months (P = .31). Symptomatic improvement was reported in 95.7% in the <4 weeks group, 96.7% in the 4- to 12-weeks group, and 93.5% in the >12 weeks group (P = .84). CONCLUSIONS: TFRR offers excellent postoperative outcomes for patients with symptomatic VTOS, even in cases of completely occluded axillosubclavian veins, regardless of the chronicity of the occlusion. By 14 months, 95.2% of patients experienced symptomatic improvement, and 75% attained venous patency.
引用
- Ng JC, Tan LT, Mofid A, et al. Surgical outcomes for occluded venous thoracic outlet syndrome following transaxillary first rib resection. J Vasc Surg Venous Lymphat Disord. 2024. PMID: 38914374. doi:10.1016/j.jvsv.2024.101925
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。